AKT1 and pancreatic neoplasm: Inhibiting the expression of TMEM158 can effectively reverse the pancreatic cancer cell proliferation, migration, and invasion induced by PI3K/AKT signaling.[54] SLC35C1 is a GDP fucose transporter negatively regulating the WNT signal pathway.